Uchida Tetsuro, Kuroda Yoshinori, Yamashita Atsushi, Hamasaki Azumi, Hirooka Shuto, Nakai Shingo, Kobayashi Kimihiro, Sadahiro Mitsuaki
Second Department of Surgery, Yamagata University, Yamagata, Japan.
Kyobu Geka. 2019 Nov;72(12):976-983.
Recently, thoracic endovascular aortic repair (TEVAR) is widely accepted and performed in patients with complicated and uncomplicated Stanford type B aortic dissection. However, TEVAR for Stanford type A aortic dissection is not commonly performed even in the endovascular era. This report describes patients who underwent TEVAR for Stanford type A dissection.
Since 2016, 5 patients underwent TEVAR for retrograde acute Stanford type A dissection. A covered stent-graft was placed in the descending aorta for primary entry coverage. An additional bare-stent was placed in the narrowed true lumen of the downstream aorta. A thrombosed false lumen was observed in 4 and a partially thrombosed lumen in 1 patient. No patient showed pericardial effusion, aortic insufficiency, or persistent back pain. Four of 5 patients were asymptomatic, and only 1 patient developed multiorgan malperfusion. Repetitive computed tomography (CT) was performed postoperatively.
All patients underwent successful TEVAR without the need for additional intervention, and no operative mortality and morbidity were observed. The patient with multiorgan malperfusion recovered uneventfully without any complication. Follow-up CT revealed complete disappearance of the false lumen in the ascending aorta in all patients.
Although TEVAR of the descending aorta was performed with acceptable mortality and morbidity rates in strictly selected patients with retrograde Stanford type A dissection, conceptual and technical issues remain unresolved in patients with ascending aortic stent-graft placement. Technological advances would lead to the development of innovative disease-specific endovascular devices and solutions in the future for TEVAR in patients with Stanford type A dissection.
近年来,胸主动脉腔内修复术(TEVAR)在复杂和非复杂的斯坦福B型主动脉夹层患者中得到广泛认可并应用。然而,即使在血管腔内治疗时代,TEVAR用于斯坦福A型主动脉夹层的情况也并不常见。本报告描述了接受TEVAR治疗斯坦福A型夹层的患者。
自2016年以来,5例患者因逆行性急性斯坦福A型夹层接受了TEVAR治疗。在降主动脉置入覆膜支架移植物以覆盖原发破口。在下游主动脉狭窄的真腔内额外置入裸支架。4例患者观察到假腔血栓形成,1例患者假腔部分血栓形成。无患者出现心包积液、主动脉瓣关闭不全或持续性背痛。5例患者中有4例无症状,仅1例患者出现多器官灌注不良。术后进行了重复计算机断层扫描(CT)。
所有患者TEVAR均成功,无需额外干预,未观察到手术死亡率和并发症。多器官灌注不良的患者恢复顺利,无任何并发症。随访CT显示所有患者升主动脉假腔完全消失。
尽管在严格选择的逆行性斯坦福A型夹层患者中进行降主动脉TEVAR的死亡率和并发症发生率可接受,但升主动脉置入支架移植物的患者在概念和技术问题上仍未解决。技术进步将导致未来开发针对斯坦福A型夹层患者TEVAR的创新性疾病特异性血管腔内装置和解决方案。